3.6211
0.0511 (1.43%)
0.0511 (1.43%)
Upgrade to Real-Time
Regular Market
Low
1.58
High
3.8799
Best deals to access real time data! |
|
Ultimate Trader (Monthly)
Monthly Subscription
for only
|
|
Small Cap Basic
Monthly Subscription
for only
|
|
Big Cap Pro
Monthly Subscription
for only
|
|
VAT not included
|
| Company Name | Stock Ticker Symbol | Market | Type |
|---|---|---|---|
| Entasis Therapeutics Holdings Inc | ETTX | NASDAQ | Common Stock |
| Price Change | Change Percent | Stock Price | Last Traded  |
|
|---|---|---|---|---|
| 0.0511 | 1.43% | 3.6211 | 11:34:18 |
| Open Price | Low Price | High Price | Close Price | Prev Close |
|---|---|---|---|---|
| 3.58 | 3.58 | 3.80 | 3.57 |
| Bid Price | Ask Price | Spread | News | |
|---|---|---|---|---|
| 3.62 | 3.63 | 0.01 | - | - |
| Trades | Volume | VWAP | Dollar Volume | Avg Volume | 52 Week Range |
|---|---|---|---|---|---|
| 558 | 185,092 | $ 3.69 | $ 683,696 | - | 1.58 - 3.8799 |
| Last Trade Time | Type | Quantity | Stock Price | Currency |
|---|---|---|---|---|
| 11:35:35 | 10 | $ 3.625 | USD |
Period:
Draw Mode:
Entasis Therapeutics Holdings Inc Financials
| Market Cap | Shares in Issue | Float | Revenue | Profit/Loss | EPS | PE Ratio |
|---|---|---|---|---|---|---|
| $ 171.32M | 47.31M | 27.08M | $ - | $ - | -2.43 | -3.20 |
| Short Interest | Dividends Per Share | Dividend Yield | Ex-Div Date | Insider B/S | Insider % Owned |
|---|---|---|---|---|---|
| - | $ - | - | 12.64M | 0.70% |
Entasis Therapeutics News
Loading Messages....
|
|
{{bbMessage.M_Alias}} {{bbMessage.MSG_Date}} {{bbMessage.HowLongAgo}} {{bbMessage.MSG_ID}} {{bbMessage.MSG_Subject}} |
Loading Messages....
Historical ETTX Price Data
| Period | Open | High | Low | VWAP | Avg. Daily Vol | Change | % |
|---|---|---|---|---|---|---|---|
| 1 Week | 2.83 | 3.8799 | 2.73 | 3.26 | 868,782 | 0.7911 | 27.95% |
| 1 Month | 2.65 | 3.8799 | 2.55 | 3.13 | 319,234 | 0.9711 | 36.65% |
| 3 Months | 2.71 | 3.8799 | 2.2088 | 2.85 | 189,660 | 0.9111 | 33.62% |
| 6 Months | 2.83 | 3.8799 | 1.76 | 2.56 | 296,984 | 0.7911 | 27.95% |
| 1 Year | 2.76 | 3.8799 | 1.58 | 2.37 | 437,239 | 0.8611 | 31.2% |
| 3 Years | 13.45 | 13.70 | 1.58 | 2.84 | 183,955 | -9.83 | -73.08% |
| 5 Years | 13.45 | 13.70 | 1.58 | 2.84 | 183,955 | -9.83 | -73.08% |
Entasis Therapeutics Description
| Entasis Therapeutics Holdings Inc is a clinical-stage biopharmaceutical company. It is engaged in the discovery, development, and commercialization of novel antibacterial products to treat serious infections caused by multi-drug resistant Gram-negative bacteria. Its products candidate includes Zoliflodacin, ETX0282CPDP, and NBP program. |
